D. Banerjee

发表

Active site-directed double mutants of dihydrofolate reductase.

M. Waltham, E. Ercikan-Abali, S. Mineishi, 1996, Cancer research.

Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress.

H. Lenz, D. Banerjee, J. Bertino, 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance

D. Banerjee, J. Bertino, P. Mishra, 2007, Proceedings of the National Academy of Sciences.

Translational Modulation of Proteins Expressed from Bicistronic Vectors

D. Banerjee, J. Bertino, P. Mishra, 2009, Molecular imaging.

Editorial [Hot Topic:Novel Targets in Cancer Therapy(Guest Editor: Debabrata Banerjee)]

D. Banerjee, 2009 .

The therapeutic potential of mesenchymal stem cells

D. Banerjee, P. Mishra, Pravin J. Mishra, 2007, Expert opinion on biological therapy.

Recovering 3 D tumor locations from 2 D bioluminescence images

Dimitris N. Metaxas, D. Banerjee, J. Bertino, 2006 .

Quantitation of Gene Copy Number and mRNA Using the Polymerase Chain Reaction

R. Fanin, D. Banerjee, J. Bertino, 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region.

M. Waltham, E. Ercikan-Abali, D. Banerjee, 1997, Biochemistry.

Keratinocyte Induced Differentiation of Mesenchymal Stem Cells into Dermal Myofibroblasts: A Role in Effective Wound Healing.

D. Banerjee, P. Mishra, Pravin J. Mishra, 2016, International journal of translational science.

Cell-free derivatives from mesenchymal stem cells are effective in wound therapy.

D. Banerjee, P. Mishra, Pravin J. Mishra, 2012, World journal of stem cells.

Differential Gene Expression Associated with Migration of Mesenchymal Stem Cells to Conditioned Medium from Tumor Cells or Bone Marrow Cells

D. Banerjee, L. Menon, J. Glod, 2007, Stem cells.

Molecular Imaging Reveals Skeletal Engraftment Sites of Transplanted Bone Marrow Cells

L. Bidaut, R. Blasberg, M. V. D. van den Brink, 2006, Cell transplantation.

Cytotoxicity and Cell Growth Assays

D. Banerjee, J. Bertino, G. Saydam, 2006 .

High-resolution imaging of bone precursor cells within the intact bone marrow cavity of living mice.

R. Blasberg, J. Koutcher, A. Boskey, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Fluoropyrimidine resistance in colon cancer

D. Banerjee, R. Gorlick, 2002, Expert review of anticancer therapy.

Gene therapy for endometrial carcinoma with the herpes simplex thymidine kinase gene.

R. Barakat, E. Ercikan-Abali, D. Banerjee, 2000, Gynecologic oncology.

Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier

D. Banerjee, J. Bertino, J. Healey, 2008, BMC Cancer.

Practical Issues with the Use of Stem Cells for Cancer Gene Therapy

D. Banerjee, A. Hatefi, F. Nouri, 2015, Stem Cell Reviews and Reports.

Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu.

D. Banerjee, Pravin J. Mishra, J. Glod, 2010, Experimental cell research.

A second target of benzamide riboside

D. Banerjee, J. Bertino, K. Scotto, 2012, Cancer biology & therapy.

Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells.

J. Mesirov, G. Alexe, D. Banerjee, 2008, Cancer research.

Stromal Carcinoma Associated Fibroblasts Promote Drug Resistance of Human Pancreatic Cancer Cells by Modulation of ROS via CXCR4/CXCL12 Signaling

D. Banerjee, B. Patel, N. Johnson, 2015 .

P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and -independent mechanisms

D. Banerjee, S. Dolfi, Christopher DeRenzo, 2013, International journal of oncology.

Macrophage-Associated Mesenchymal Stem Cells Assume an Activated, Migratory, Pro-Inflammatory Phenotype with Increased IL-6 and CXCL10 Secretion

D. Banerjee, J. Glod, K. Anton, 2012, PloS one.

AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cells.

Steven J. Greco, D. Banerjee, P. Rameshwar, 2011, American journal of cancer research.

Original Article AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cells

Steven J. Greco, D. Banerjee, Shyam A. Patel, 2011 .

mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma.

A. Huvos, D. Banerjee, J. Bertino, 2003, Molecular cancer therapeutics.

E2F-1 overexpression in U2OS cells increases cyclin B1 levels and cdc2 kinase activity and sensitizes cells to antimitotic agents.

D. Banerjee, J. Bertino, Wei-Wei Li, 2006, Cancer research.

A . Dye Exclusion Test Using Trypan Blue

D. Banerjee, J. Bertino, G. Longo-Sorbello, 2007 .

Antisense Therapy

D. Banerjee, 2003 .

Is the measurement of thymidylate synthase to determine suitability for treatment with 5-fluoropyrimidines ready for prime time?

D. Banerjee, J. Bertino, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Higher levels of thymidylate synthase gene expression are observed in pulmonary as compared with hepatic metastases of colorectal adenocarcinoma.

S. Jhanwar, N. Kemeny, D. Banerjee, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Imaging Colon Cancer Response Following Treatment with AZD1152: A Preclinical Analysis of [18F]Fluoro-2-deoxyglucose and 3′-deoxy-3′-[18F]Fluorothymidine Imaging

R. Blasberg, G. Schwartz, D. Banerjee, 2011, Clinical Cancer Research.

Resistance Mechanisms to Methotrexate in Tumors

D. Banerjee, J. Bertino, W. Li, 1996, Stem cells.

Modeling and antitumor studies of a modified L–penetratin peptide targeting E2F in lung cancer and prostate cancer

D. Banerjee, J. Bertino, K. Scotto, 2018, Oncotarget.

Imaging of dihydrofolate reductase fusion gene expression in xenografts of human liver metastases of colorectal cancer in living rats

S. Larson, N. Gusani, R. Blasberg, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Molecular therapies for colorectal cancer metastatic to the liver.

N. Kemeny, D. Banerjee, J. Bertino, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Characterization and drug sensitivity of four newly established colon adenocarcinoma cell lines to antifolate inhibitors of thymidylate synthase.

S. Jhanwar, D. Banerjee, J. Bertino, 2001, Oncology research.

Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase.

C. Cordon-Cardo, S. Jhanwar, D. Banerjee, 2000, Cancer research.

Novel targets in cancer therapy.

D. Banerjee, 2009, Current pharmaceutical biotechnology.

Macrophages play a key role in early blood brain barrier reformation after hypothermic brain injury

D. Banerjee, N. Rooijen, D. Kobiler, 2011, Neuroscience Letters.

Comparison of the expression of a mutant dihydrofolate reductase under control of different internal promoters in retroviral vectors.

E. Gilboa, D. Banerjee, B. Schweitzer, 1992, Human gene therapy.

Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab

D. Banerjee, J. Bertino, J. Jimeno, 2012, Cancer biology & therapy.

Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.

G. Wahl, D. Banerjee, J. Bertino, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene

S. Mineishi, S. Nakahara, D. Banerjee, 1997, Gene Therapy.

Decreased levels of UMP kinase as a mechanism of fluoropyrimidine resistance

N. Kemeny, D. Banerjee, J. Bertino, 2009, Molecular Cancer Therapeutics.

Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivity.

Thomas D. Schmittgen, A. Schönthal, H. Lenz, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Modulation of cytotoxicity of chemotherapeutic drugs by activated H-ras.

D. Banerjee, J. Bertino, P. Stambrook, 1997, Biochemical pharmacology.

p14ARF Expression Increases Dihydrofolate Reductase Degradation and Paradoxically Results in Resistance to Folate Antagonists in Cells with Nonfunctional p53

D. Banerjee, J. Bertino, Wei-Wei Li, 2004, Cancer Research.

Pre-clinical toxicology and pathology of 9-(2'-hydroxyethylamino)-4-methyl-1-nitroacridine (C-1748), a novel anti-cancer agent in male Beagle dogs.

D. Banerjee, R. Tiwari, K. Tadi, 2006, Life sciences.

Heparin and Suramin Alter Plitidepsin Uptake Via Inhibition of GPCR Coupled Signaling

D. Banerjee, J. Bertino, H. Gao, 2009, Journal of chemotherapy.

Antitumor and modeling studies of a penetratin-peptide that targets E2F-1 in small cell lung cancer

D. Banerjee, J. Bertino, K. Scotto, 2013, Cancer biology & therapy.

Myeloprotection with drug-resistance genes.

D. Banerjee, J. Bertino, 2002, The Lancet. Oncology.

Role of E2F-1 in chemosensitivity.

D. Banerjee, J. Bertino, B. Schnieders, 1998, Cancer research.

Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction

E. Gilboa, S. Mineishi, D. Banerjee, 1994 .

Sequence analysis of polymerase chain reaction amplified t(14;18) chromosomal breakpoints in formalin fixed, paraffin wax embedded follicular lymphoma.

R. Fanin, D. Banerjee, J. Bertino, 1992, Journal of clinical pathology.

Identification and Characterization of Monoclonal Lymphoid Populations by Analysis of Complementary RNA of Clonespecific DNA Sequences

J. Buer, H. Lenz, D. Banerjee, 1994 .

Thymidylate synthase as an oncogene?

D. Banerjee, J. Bertino, 2004, Cancer cell.

Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.

Debabrata Banerjee, Richard Gorlick, D. Banerjee, 2002, Biochimica et biophysica acta.

Novel Therapeutic Approaches to Regulate Human Dihydrofolate Reductase Activity and Expression

D. Banerjee, J. Bertino, Y. Hsieh, 2012 .

Polymerase chain reaction analysis of DNA from paraffin-embedded tissue.

R. Fanin, D. Banerjee, J. Bertino, 1993, Methods in molecular biology.

Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer

D. Banerjee, D. Mishra, 2023, Cells.

Epigenetic reversal of acquired resistance to 5-fluorouracil treatment

D. Banerjee, J. Bertino, P. Mishra, 2009, Molecular Cancer Therapeutics.

Protection of Hematopoietic Progenitor Cells from Chemotherapy Toxicity by Transfer of Drug Resistance Genes

D. Banerjee, J. Bertino, N. Takebe, 1998 .

Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.

D. Banerjee, J. Bertino, M. Moore, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics

D. Banerjee, J. Bertino, P. Mishra, 2008, Cell cycle.

Nitric Oxide and S-Nitrosylation in Cancers: Emphasis on Breast Cancer

D. Banerjee, V. Patel, D. Mishra, 2020, Breast cancer : basic and clinical research.

Transformation of benign Barrett's epithelium by repeated acid and bile exposure over 65 weeks: A novel in vitro model

D. Banerjee, Diptee A. Kulkarni, K. Hirshfield, 2011, International journal of cancer.

Effects of wild‐type p53 expression on the quantity and activity of topoisomerase IIα and β in various human cancer cell lines

John A. Hartley, Joseph R. Bertino, Debabrata Banerjee, 1999 .

Effects of wild-type p53 expression on the quantity and activity of topoisomerase IIalpha and beta in various human cancer cell lines.

D. Banerjee, J. Bertino, D. Sullivan, 1999, Journal of cellular biochemistry.

Overexpression of E2F-1 in Lung and Liver Metastases of Human Colon Cancer is Associated with Gene Amplification

S. Jhanwar, N. Kemeny, D. Banerjee, 2004, Cancer biology & therapy.

Activation of Signal Transducers and Activators of Transcription 3 and Focal Adhesion Kinase by Stromal Cell‐Derived Factor 1 Is Required for Migration of Human Mesenchymal Stem Cells in Response to Tumor Cell‐Conditioned Medium

D. Banerjee, W. Priebe, J. Glod, 2009, Stem cells.

p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival.

S. Groshen, H. Lenz, D. Banerjee, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts

K. Pradhan, A. Maitra, S. Batra, 2019, eLife.

Gene therapy utilizing drug resistance genes: A review

S. Mineishi, D. Banerjee, B. Schweitzer, 1994, Stem cells.

Protection of hematopoietic stem cells from pemetrexed toxicity by retroviral gene transfer with a mutant dihydrofolate reductase-mutant thymidylate synthase fusion gene

F. Maley, D. Banerjee, J. Bertino, 2004, Cancer Gene Therapy.

Retroviral transduction of a mutant dihydrofolate reductase-thymidylate synthase fusion gene into murine marrow cells confers resistance to both methotrexate and 5-fluorouracil.

F. Maley, D. Banerjee, J. Bertino, 2003, Human gene therapy.

Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: A method to modulate gene expression

S. Larson, R. Blasberg, D. Banerjee, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Retroviral transduction of human dihydropyrimidine dehydrogenase cDNA confers resistance to 5-fluorouracil in murine hematopoietic progenitor cells and human CD34+-enriched peripheral blood progenitor cells

Martin R. Johnson, R. Diasio, D. Banerjee, 2001, Cancer Gene Therapy.

Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.

S. Mineishi, D. Banerjee, M. Sadelain, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors

S. Nakahara, D. Banerjee, J. Bertino, 2000, Cancer Gene Therapy.

Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside.

J. McPherson, D. Banerjee, J. Bertino, 1999, Human gene therapy.

Protection of Marrow from Methotrexate Toxicity by Gene Transfer of Mutant Forms of Dihydrofolate Reductase into Hematopoietic Progenitor Cells

E. Ercikan-Abali, S. Mineishi, D. Banerjee, 1998 .

Retroviral transduction of human CD34+ umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNA.

J. Leonard, S. Mineishi, D. Banerjee, 1998, Human gene therapy.

Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer.

S. Mineishi, D. Banerjee, J. Bertino, 1995, Blood.

Molecular detection and characterization of clonal cell populations in acute lymphocytic leukemia by analysis of conformational polymorphisms of cRNA molecules of rearranged T-cell-receptor-gamma and immunoglobulin heavy-chain genes.

J. Buer, D. Banerjee, J. Bertino, 1994, Leukemia.

E2F-1 as an anticancer drug target

D. Banerjee, J. Bertino, 2011 .

Intrinsic and acquired resistance to methotrexate in acute leukemia.

M. Waltham, D. Banerjee, J. Bertino, 1996, The New England journal of medicine.

Bone Marrow Derived Mesenchymal Stem/Stromal Cells and Tumor Growth

D. Banerjee, Pravin J. Mishra, 2010 .

Hematopoietic stem cell gene therapy with drug resistance genes: an update

D. Banerjee, J. Bertino, T. Budak-Alpdogan, 2005, Cancer Gene Therapy.

Overexpression of p21(waf1) decreases G2-M arrest and apoptosis induced by paclitaxel in human sarcoma cells lacking both p53 and functional Rb protein.

D. Banerjee, J. Bertino, W. Li, 1999, Molecular pharmacology.

Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase.

E. Gilboa, S. Mineishi, D. Banerjee, 1994, Cancer gene therapy.

Increased Photosensitivity in HL60 Cells Expressing Wild‐Type p53

C. Gomer, A. Fisher, D. Banerjee, 1997, Photochemistry and photobiology.

Metabolic Interactions Between Tumor and Stromal Cells in the Tumor Microenvironment.

D. Banerjee, D. Mishra, 2021, Advances in experimental medicine and biology.

Chemokines at the crossroads of tumor‐fibroblast interactions that promote malignancy

D. Banerjee, A. Ben-Baruch, Pravin J. Mishra, 2011, Journal of leukocyte biology.

Protein kinase C zeta regulates interleukin-8-mediated stromal-derived factor-1 expression and migration of human mesenchymal stromal cells.

D. Banerjee, J. Glod, Sonia C Picinich, 2010, Experimental cell research.

Mesenchymal stem cells: flip side of the coin.

D. Banerjee, P. Mishra, Pravin J. Mishra, 2009, Cancer research.

Cancer Vaccines: Bench to Bedside

D. Banerjee, R. Tiwari, J. Geliebter, 2016 .

The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells.

D. Banerjee, A. Everett, Pravin J. Mishra, 2008, Experimental cell research.

Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway

D. Banerjee, T. Meshel, I. Kamer, 2015, Stem Cell Research & Therapy.

Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment.

J. Koutcher, D. Banerjee, B. Patel, 2012, Experimental cell research.

Use of variants of dihydrofolate reductase in gene transfer to produce resistance to methotrexate and trimetrexate.

E. Ercikan-Abali, S. Mineishi, D. Banerjee, 1999, Progress in experimental tumor research.

Post-transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA.

S. Mineishi, D. Banerjee, J. Bertino, 1997, Human gene therapy.

Transfection with a cDNA encoding a Ser31 or Ser34 mutant human dihydrofolate reductase into Chinese hamster ovary and mouse marrow progenitor cells confers methotrexate resistance.

M. Waltham, S. Mineishi, D. Banerjee, 1994, Gene.

Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction.

E. Gilboa, S. Mineishi, D. Banerjee, 1994, Blood.

Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancer

Z. Darżynkiewicz, D. Banerjee, R. Tiwari, 2007, Cancer biology & therapy.

Capridine β (C-1748): A novel 1-nitroacridine derivative targets the cyclin dependent kinase, cdk4, and the tumor suppressor gene, p16 in prostate cancer.

D. Banerjee, R. Tiwari, K. Tadi, 2004 .

Pretreatment of endometrial carcinoma cell lines with butyrate results in upregulation of Bax and correlates with potentiation of radiation induced cell kill.

R. Barakat, D. Banerjee, J. Bertino, 2000, In vivo.

Acute monocytic leukemia: a myeloid leukemia subset that may be sensitive to methotrexate.

M. Waltham, D. Banerjee, J. Bertino, 1995, Leukemia.

Tumor initiating cells.

D. Banerjee, Nitu Bansal, 2009, Current pharmaceutical biotechnology.

Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment

D. Banerjee, D. Mishra, 2019, Cancers.

Dihydrofolate reductase as an oncogene: a microRNA binding site SNP leads to cellular transformation and drug resistance

D. Banerjee, J. Bertino, P. Mishra, 2008 .

MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism

D. Banerjee, J. Bertino, G. Merlino, 2009, PloS one.

A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts

D. Banerjee, J. Bertino, K. Scotto, 2014, Oncotarget.

Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity

D. Banerjee, J. Bertino, G. Saydam, 2007, Leukemia.

Species-Specific Differences in Translational Regulation of Dihydrofolate Reductase

D. Banerjee, J. Bertino, K. Scotto, 2009, Molecular Pharmacology.

Identification of Amino Acids Required for the Functional Up-regulation of Human Dihydrofolate Reductase Protein in Response to Antifolate Treatment*

D. Banerjee, J. Bertino, P. Mishra, 2005, Journal of Biological Chemistry.

Probing the Folate-binding Site of Human Thymidylate Synthase by Site-directed Mutagenesis

F. Maley, E. Ercikan-Abali, D. Banerjee, 1998, The Journal of Biological Chemistry.

Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.

E. Ercikan-Abali, D. Banerjee, J. Bertino, 1996, Journal of the National Cancer Institute.

Molecular mechanisms of resistance to antifolates, a review.

M. Waltham, E. Ercikan-Abali, D. Banerjee, 1995, Acta biochimica Polonica.

Translational regulation of the synthesis of dihydrofolate reductase.

M. Waltham, D. Banerjee, J. Bertino, 1993, Advances in experimental medicine and biology.

Isolation and Characterization of Thymitaq (AG337) and 5-Fluoro-2-deoxyuridylate-resistant Mutants of Human Thymidylate Synthase from Ethyl Methanesulfonate-exposed Human Sarcoma HT1080 Cells*

E. Ercikan-Abali, D. Banerjee, J. Bertino, 1998, The Journal of Biological Chemistry.

Enhanced Degradation of Dihydrofolate Reductase through Inhibition of NAD Kinase by Nicotinamide Analogs

D. Banerjee, J. Bertino, K. Scotto, 2013, Molecular Pharmacology.

Tumor stroma interaction is mediated by monocarboxylate metabolism

R. Blasberg, J. Koutcher, D. Banerjee, 2017, Experimental cell research.

Subverting Subversion: A Review on the Breast Cancer Microenvironment and Therapeutic Opportunities

D. Banerjee, E. Rothschild, 2015, Breast cancer : basic and clinical research.

Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer.

C. Cordon-Cardo, M. Gonen, D. Banerjee, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thymidylate S ynthase E xpression i n H epatic T umors I s a Predictor o f S urvival a nd P rogression i n P atients W ith Resectable M etastatic C olorectal C ancer

C. Cordon-Cardo, M. Gonen, D. Banerjee, 2003 .

Sequence-dependent synergistic cytotoxicity of ecteinascidin-743 and paclitaxel in human breast cancer cell lines in vitro and in vivo.

Debabrata Banerjee, T. Chou, D. Banerjee, 2002, Cancer research.

Activation and Differentiation of Mesenchymal Stem Cells.

D. Banerjee, Pravin J. Mishra, 2017, Methods in molecular biology.

Strategies for Imaging Biology in Cancer and Other Diseases

D. Banerjee, P. Mayer‐Kuckuk, 2008 .

Preclinical toxicological examination of a putative prostate cancer-specific 4-methyl-1-nitroacridine derivative in rodents

D. Banerjee, R. Tiwari, Qiang Huang, 2007, Anti-cancer drugs.

Induction of androgen receptor by a novel nitroacridine, C-1748: Implications for its role as a chemotherapeutic agent in hormone independent prostate cancer

D. Banerjee, R. Tiwari, K. Tadi, 2005 .

Identification and characterization of a mutation in the dihydrofolate reductase gene from the methotrexate-resistant Chinese hamster ovary cell line Pro-3 MtxRIII.

D. Banerjee, B. Schweitzer, J. Bertino, 1990, The Journal of biological chemistry.

Elevated extracellular CO2 level affects the adaptive transcriptional response and survival of human peripheral blood mononuclear cells toward hypoxia and oxidative stress

D. Banerjee, S. Wanandi, I. F. Amin, 2021 .

Sequence-dependent enhancement of cytotoxicity produced by ecteinascidin 743 (ET-743) with doxorubicin or paclitaxel in soft tissue sarcoma cells.

D. Banerjee, J. Bertino, K. Scotto, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Practical Issues with the Use of Stem Cells for Cancer Gene Therapy

D. Banerjee, A. Hatefi, F. Nouri, 2015, Stem Cell Reviews and Reports.

Role of reporter gene imaging in molecular and cellular biology

R. Blasberg, D. Banerjee, J. Bertino, 2004, Biological chemistry.

Advances in Brief Role of E 2 F-1 in Chemosensitivity 1

D. Banerjee, J. Bertino, B. Schnieders, 2006 .

Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.

M. Waltham, E. Ercikan-Abali, D. Banerjee, 1996, Molecular pharmacology.

Pharmacogenomics of microRNA: a miRSNP towards individualized therapy.

D. Banerjee, J. Bertino, P. Mishra, 2007, Pharmacogenomics.

Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.

M. Waltham, R. Fanin, D. Banerjee, 1993, Molecular pharmacology.

Molecular targets for epigenetic therapy of cancer.

D. Banerjee, J. Bertino, P. Mishra, 2009, Current pharmaceutical biotechnology.

Correlate with Levels of Thymidylate Synthase Colon Cancer As Compared with Hepatic Metastasis and Levels of E 2 F-1 Expression Are Higher in Lung Metastasis of Updated

C. Cordon-Cardo, S. Jhanwar, D. Banerjee, 2000 .

Purine salvage rescue by xanthine-guanine phosphoribosyltransferase (XGPRT) potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.

S. Mineishi, S. Nakahara, D. Banerjee, 1998, Cancer gene therapy.

Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment.

J. Koutcher, D. Banerjee, B. Patel, 2012, Experimental cell research.

Chemokines at the crossroads of tumor‐fibroblast interactions that promote malignancy

D. Banerjee, A. Ben-Baruch, Pravin J. Mishra, 2011, Journal of leukocyte biology.